Clinical monitoring for people with HIV and serological evidence of HBV exposure in the era of anti-retroviral therapy without hepatitis B active agents

In this audit of PWHIV and current or prior HBV exposure, 12/183 patients were switched to HBV-inactive ART. There were significant variations in testing practice performed pre- and post-switch to monitor potential HBV activity. Consistency between guidelines would enhance implementation efforts in our context.